|Environment dominates over host genetics in shaping human gut microbiota|
D Rothschild, O Weissbrod, E Barkan, A Kurilshikov, T Korem, D Zeevi, ...
Nature 555 (7695), 210-215, 2018
|COVID-19 dynamics after a national immunization program in Israel|
H Rossman, S Shilo, T Meir, M Gorfine, U Shalit, E Segal
Nature medicine 27 (6), 1055-1061, 2021
|Axes of a revolution: challenges and promises of big data in healthcare|
S Shilo, H Rossman, E Segal
Nature medicine 26 (1), 29-38, 2020
|A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys|
H Rossman, A Keshet, S Shilo, A Gavrieli, T Bauman, O Cohen, E Shelly, ...
Nature Medicine 26 (5), 634-638, 2020
|Longitudinal symptom dynamics of COVID-19 infection|
B Mizrahi, S Shilo, H Rossman, N Kalkstein, K Marcus, Y Barer, A Keshet, ...
Nature communications 11 (1), 1-10, 2020
|Prediction of gestational diabetes based on nationwide electronic health records|
NS Artzi, S Shilo, E Hadar, H Rossman, S Barbash-Hazan, ...
Nature medicine 26 (1), 71-76, 2020
|Hospital load and increased COVID-19 related mortality in Israel|
H Rossman, T Meir, J Somer, S Shilo, R Gutman, A Ben Arie, E Segal, ...
Nature communications 12 (1), 1-7, 2021
|Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case–control study|
S Shilo, MV Assous, T Lachish, P Kopuit, T Bdolah-Abram, AM Yinnon, ...
Infection 41 (2), 503-509, 2013
|Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study|
CH Sudre, A Keshet, MS Graham, AD Joshi, S Shilo, H Rossman, ...
The Lancet Digital Health 3 (9), e577-e586, 2021
|A prediction model to prioritize individuals for a SARS-CoV-2 test built from national symptom surveys|
S Shoer, T Karady, A Keshet, S Shilo, H Rossman, A Gavrieli, T Meir, ...
Med 2 (2), 196-208. e4, 2021
|Building an international consortium for tracking coronavirus health status|
E Segal, F Zhang, X Lin, G King, O Shalem, S Shilo, WE Allen, ...
Nature medicine 26 (8), 1161-1165, 2020
|Signals of hope: gauging the impact of a rapid national vaccination campaign|
S Shilo, H Rossman, E Segal
Nature Reviews Immunology 21 (4), 198-199, 2021
|Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children|
M Cohen, N Leibovitz, S Shilo, N Zuckerman‐Levin, I Shavit, N Shehadeh
Pediatric diabetes 18 (4), 290-296, 2017
|Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis|
S Shilo, O Michaeli, E Shahar, S Ravid
European Journal of Paediatric Neurology 20 (3), 361-367, 2016
|Personalized Postprandial Glucose Response–Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes|
O Ben-Yacov, A Godneva, M Rein, S Shilo, D Kolobkov, N Koren, ...
Diabetes care 44 (9), 1980-1991, 2021
|Aggregatibacter actinomycemcomitans pneumonia in children: two case reports and a review of the literature|
S Shilo, I Kassis, F Hakim, Y Shachor-Meyouhas
The Pediatric infectious disease journal 34 (1), 100-102, 2015
|Stress-related emotional and behavioural impact following the first COVID-19 outbreak peak|
A Benjamin, Y Kuperman, N Eren, R Rotkopf, M Amitai, H Rossman, ...
Molecular psychiatry 26 (11), 6149-6158, 2021
|Clinically accurate prediction of glucose levels in patients with type 1 diabetes|
Y Amar, S Shilo, T Oron, E Amar, M Phillip, E Segal
Diabetes technology & therapeutics 22 (8), 562-569, 2020
|Identifying sources of support and barriers to physical activity in pediatric type 1 diabetes|
R Livny, W Said, S Shilo, R Bar‐Yoseph, S Gal, M Oren, M Levy, R Weiss, ...
Pediatric diabetes 21 (1), 128-134, 2020
|The effect of a national lockdown in response to COVID-19 pandemic on the prevalence of clinical symptoms in the population|
A Keshet, A Gavrieli, H Rossman, S Shilo, T Meir, T Karady, A Lavon, ...